CClinicalTrials.gg
CompletedNCT05284721Updated Aug 3, 2026

Family Peer Navigator for Early Psychosis for Black Families

An interventional study of Family Peer Navigator for Early Psychosis and Care Coordination in Family Members, sponsored by Washington State University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by Washington State University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Building upon formative research, this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African American families.

Read the detailed description

The overall goal of this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and engagement in coordinated specialty care programs among Black/African American families. Phase II will recruit 10 family member participants to complete a four-month open trial to refine the Family Peer Navigator model. During Phase III, a total of 40 Black/African American families will be recruited to participate in a randomized pilot trial of the Family Peer Navigator model against a low-intensive care coordination in two coordinated specialty care programs to assess acceptability, feasibility, and preliminary impact.

02

Conditions studied

  • Family Members

Browse trials for

Keywords

  • Black/African American
  • Early Psychosis
  • Access and Engagement
03

In context

Psychotic Disorders

1,626 studies on the registry are indexed under Psychotic Disorders; 293 are open to participants now.

This study's enrollment of 36 is below the median of 70 across 1,333 interventional studies indexed under Psychotic Disorders.

Browse Psychotic Disorders studies →

Lead sponsor

Washington State University is the lead sponsor of 82 studies on the registry; 16 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 3 (43%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. ≥ 18 years of age
  2. Identifies as Black/African American
  3. Loved one who meets criteria for risk of psychosis with a total score of ≥ 3 on the Prodromal Questionnaire- Brief Version

Exclusion criteria

Exclusion Criteria:

  1. Family members who cannot understand the consent process
  2. Non-English speaking adults
  3. Black/African American families referred to coordinated specialty care and who have already been determined eligible for services by providers.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Active comparator
    Care Coordination Phase III

    Family member participants randomized to the active control will receive two brief psychoeducation sessions, two brief check ins across one month and linked to appropriate services.

    Behavioral: Care Coordination

  • Experimental
    Family Peer Navigator model Psychosis Phase III

    Family member participants randomized to the Family Peer Navigator condition will participate in two sessions for introduction/assessment, four individual psychoeducation sessions, and six brief check ins delivered by Family Peer Navigators.

    Behavioral: Family Peer Navigator for Early Psychosis

Interventions

  • BehavioralFamily Peer Navigator for Early Psychosis

    The Family Peer Navigator model is theoretical underpinning by the Social-Ecological Model and the Social Cognitive Theory, that incorporates a mixture of evidence- and research-based strategies, to include three key components: 1) Introduction and Assessment; 2) Individual Psychoeducation; 3) Six Brief Check-In

  • BehavioralCare Coordination

    active control, treatment as usual including services provided by the coordinated specialty care program for first-episode psychosis.

06

What researchers measure

Primary outcomes

  1. Client Satisfaction Questionnaire-8 (CSQ-8)

    Self-report measure to assess acceptability, a brief measure for family member participant. Items are scored from 1 to 4. Possible total scores range from 8 to 32, with higher scores (\>23) indicating greater satisfaction.

    Time frame: Months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

  2. Youth Services Survey-Families (YSS-F)

    Self-report measure to assess acceptability in the following domains: appropriateness, participation, cultural sensitivity, social connectedness, and outcomes. Items in a domain are summed and divided by the total number of items, and scores greater than 3.5 are reported in the positive range for the domain.

    Time frame: Baseline and Month 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

  3. Number of Referrals (Recruitment) to assess feasibility

    The number of family member participants recruited and referrals received categorized by where they originated.

    Time frame: Baseline through study completion; repeated measure to assess change in feasibility through study completion, average of 4 months

  4. Level of Engagement to measure feasibility

    Total number of sessions attended, the number of contact hours with families and by which method (videoconference, in person, text, email etc.) and the number of completed measures.

    Time frame: Baseline through study completion; repeated measure to assess change in feasibility through study completion, average of 4 months

  5. Rate of Retention to measure feasibility

    The percentage of families that drop out (family declined or missed 3 consecutive appointments).

    Time frame: Baseline through study completion; repeated measure to assess change in feasibility through study completion, average of 4 months

Secondary outcomes

  1. General Self-Efficacy scale

    A self report measure of self-efficacy correlated to emotion, optimism and work satisfaction. Scores range from 10 to 40 with higher scores indicating more self-efficacy.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  2. Youth Services Survey for Families - Social Connectedness Subscale

    Social connectedness will be measured using four questions (e.g., "I know people who will listen and understand me when I need to talk") from the YSS-F. Scores range from 4 to 20, higher scores indicating greater social connectedness.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  3. Culturally-adapted Knowledge about Psychosis questionnaire (CaKAP)

    Self-reported measure that includes 23 culturally specific items across five subscales: symptoms and problems relating to psychosis; cause; other treatments and services; course and outcome; and management. Total scores range from 0 through 104 where higher scores indicate greater knowledge.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  4. Youth Services Survey for Families - Cultural Sensitivity Subscale

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  5. Scale to Assess Therapeutic Relationships in Community Mental Health Care (STAR)

    Measure includes 12-items to assess therapeutic relationships.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

Other outcomes

  1. Time from Referral to Enrollment to assess

    Provider reported measure used to assess the access to coordinated specialty care programs which a participant had as defined as the time between point of referral to receipt of mental health service.

    Time frame: Baseline through study completion, average of 4 months

  2. Initial Engagement to assess preliminary effectiveness

    Provider reported measure defined as \>1 attendance or contact for the family appointment within 30 days of loved ones' intake in mental health program.

    Time frame: Baseline through study completion, average of 4 months

  3. Adherence to model

    Feasibility checklists to measure the amount and percentage of components delivered. A structured meeting log will be maintained by study staff to document solutions, barriers and challenges to implementation as well as the number of meetings scheduled and attended.

    Time frame: Baseline through study completion; repeated measure to assess the implementation feasibility of services through study completion, average of 4 months

07

Study locations

1 site
  • New Journeys: Coordinated Specialty care
    Seattle, Washington 98198, United States
08

References and documents

Publications

  • Oluwoye O, Stokes BI, Burduli E, Kriegel LS, Hoagwood KE. Community-based family peer navigator programme to facilitate linkage to coordinated specialty care for early psychosis among Black families in the USA: A protocol for a hybrid type I feasibility study. BMJ Open. 2023 Jul 5;13(7):e075729. doi: 10.1136/bmjopen-2023-075729. PubMed 37407058 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05284721
Lead sponsor
Washington State University
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Oladunni Oluwoye (Assistant Professor, Washington State University) — Principal investigator
First posted
Mar 17, 2022
Start date
Jan 1, 2023
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026
Last update
Aug 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion